Valeant CEO Joseph Papa made $62.7 million last year

Valeant Pharmaceuticals International Inc. Chief Executive Joseph Papa received compensation last year valued at $62.7 million, after the drug-industry veteran was tapped to take over the struggling drug company suffering from accounting problems, high debt levels and an image issue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.